Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Steardo

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Acta Neurologica|August 1, 1992
Long-term treatment with carbamazepine affects CSF somatostatin immunoreactivity in epileptic patientsL Steardo, N Testa, J Perez, et al.
European Journal of Pharmacology|October 1, 1984
Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptorsM Knight, C A Tamminga, L Steardo, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's diseaseL Trabace, T Cassano, L Steardo, et al.
Journal of Neurochemistry|September 1, 1985
CCK26-33 degrading activity in brain and nonneural tissue: a metalloendopeptidaseL Steardo, M Knight, C A Tamminga, et al.
Cellular and Molecular Life Sciences : CMLS|April 20, 2004
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brainM Valenti, D ViganĂ², M G Casico, et al.
Brain Research|June 19, 2001
Long-lasting handling affects behavioural reactivity in adult rats of both sexes prenatally exposed to diazepamC Cannizzaro, M Martire, E Cannizzaro, et al.
Psychoneuroendocrinology|January 1, 1985
Differential responses in prolactin levels induced by naloxone in humansL Steardo, P Monteleone, C A Tamminga, et al.
Brain Research|August 8, 2001
Effects of ENA713 and CHF2819, two anti-Alzheimer's disease drugs, on rat amino acid levelsL Trabace, T Cassano, R Cagiano, et al.
International Journal of Immunopathology and Pharmacology|November 4, 2015
Enteric glia: A new player in inflammatory bowel diseasesE Capoccia, C Cirillo, S Gigli, et al.
Neurology|August 1, 1986
Huntington's disease: effect of cysteamine, a somatostatin-depleting agentC Shults, L Steardo, P Barone, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Acta Neurologica|August 1, 1992
Long-term treatment with carbamazepine affects CSF somatostatin immunoreactivity in epileptic patientsL Steardo, N Testa, J Perez, et al.
European Journal of Pharmacology|October 1, 1984
Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptorsM Knight, C A Tamminga, L Steardo, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's diseaseL Trabace, T Cassano, L Steardo, et al.
Journal of Neurochemistry|September 1, 1985
CCK26-33 degrading activity in brain and nonneural tissue: a metalloendopeptidaseL Steardo, M Knight, C A Tamminga, et al.
Cellular and Molecular Life Sciences : CMLS|April 20, 2004
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brainM Valenti, D ViganĂ², M G Casico, et al.
Brain Research|June 19, 2001
Long-lasting handling affects behavioural reactivity in adult rats of both sexes prenatally exposed to diazepamC Cannizzaro, M Martire, E Cannizzaro, et al.
Psychoneuroendocrinology|January 1, 1985
Differential responses in prolactin levels induced by naloxone in humansL Steardo, P Monteleone, C A Tamminga, et al.
Brain Research|August 8, 2001
Effects of ENA713 and CHF2819, two anti-Alzheimer's disease drugs, on rat amino acid levelsL Trabace, T Cassano, R Cagiano, et al.
International Journal of Immunopathology and Pharmacology|November 4, 2015
Enteric glia: A new player in inflammatory bowel diseasesE Capoccia, C Cirillo, S Gigli, et al.
Neurology|August 1, 1986
Huntington's disease: effect of cysteamine, a somatostatin-depleting agentC Shults, L Steardo, P Barone, et al.
Pageof 10